We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Pre-market futures are in the red this morning, though we wouldn’t be surprised if this turns around at some point during normal trading today. The reason for this" We have a lot of economic data released ahead of the bell, and all of it — all of it — is very, very good.
Weekly Jobless Claims Stay Tame
For about four months or so, Initial Jobless Claims have mostly remained below where many analysts had expected them to go: downward, and staying there. Last week, we saw +208K new claims, down from the +210K consensus though up from the slightly upwardly revised +200K the prior week. It’s possible we’re looking at some seasonal fog in terms of initial claims, so we’ll shelve a long-term verdict for now.
Continuing Claims came up a bit week over week to 1.914 million from the downwardly revised 1.858 million the previous week. This makes the fifth-straight month below the 1.94 million level, where we were for much of the fall. The one-year low came Thanksgiving Week, 1.83 million, while the high was 1.97 million back in July. We’d spend nearly 30 weeks between 1.90 and 1.97 million without ever broaching 2 million longer-term claims, which would change the narrative about a healthy labor market.
U.S. Productivity +4.9%, Trade Deficit -$29.4B
Preliminary Q3 Productivity — the “secret sauce” to the domestic economy, according to sages such as Warren Buffett — reached +4.9% in Q3, up from the strong upward revision of 80 basis points (bps) to +4.1% in the prior quarter. This nudges past 2023 highs and notches the highest level since the 20%+ in the economic comeback after the huge Covid drop in 2020.
Meanwhile, the delayed U.S. Trade Deficit halved expectations to -$29.4 billion — the lowest print since June 2009, and less than a third of what this same deficit was directly ahead of April tariffs: -$136 billion in March. Imports fell while Exports — particularly gold and pharmaceuticals — rose. At first glance, this is extraordinarily good news; what we may need to examine, however, is whether demand issues threaten to gum up the works.
What to Expect from the Stock Market Today
Bond yields are currently flat and market indexes — Dow -177 points, S&P 500 and Russell 2000 -8 points, Nasdaq -47 points — are negative. We’re still seeing positive trading yields in the past month and year to date; perhaps only having reached all-time highs is curbing investors’ appetite this morning. There do not appear to be any discernible headwinds economically.
Then again, let’s re-visit after tomorrow’s non-farm payrolls from the U.S. Bureau of Labor Statistics (BLS).
Finally, U.S. Consumer Credit is expected to be released as today’a closing bell sounds. This is a backward-looking November print, but is anticipated to remain steady at $9.2 billion. Cannabis-harvesting major Tilray BrandsTLRY reports fiscal Q3 earnings after the close, expected to bring in +86% earnings growth on relatively flat revenues. Tilray is a Zacks Rank #3 (Hold), and looks for its third-straight earnings beat.
We cover more than 1,000 of the most widely followed stocks in our Equity Research Reports. Each report features independent research from our analysts and provides in-depth analysis on a company, its fundamentals and its growth prospects. Quickly access reports for New Upgrades and New Downgrades.
You can also find a report on the ticker of your choice, or access all of the stock reports covered by Zacks analysts.
Strategic alliances and Morgan Stanley’s increased focus on less capital market-dependent operations are expected to aid growth. Enhanced capital distribution activities reflect a solid balance sheet.
First Solar continues to expand its manufacturing capacity, which in turn is expected to boost its revenue stream. Moreover, solid financial position should benefit the company.
Hologic gains from the strategic placement of durable growth drivers across its franchises. Strong solvency and a focused capital deployment strategy buoy optimism.
Dominant position in the core material processing market, vertically integrated business model, industry-leading operating margins and expansion in TAM are key positives.
Royal Gold is likely to benefit from ramping up of new projects and solid streaming agreements. Focus on acquisitions and new business investments aided by a deleveraged strong balance sheet bode well.
Public sector’s ongoing transition to cloud-based solutions from on-premise and outdated systems bodes well for Tyler. Stable revenue base and strategic acquisitions are key positives.
Jack Henry benefits from solid momentum across commercial banks, credit unions and other financial institutions. Positive contributions from strategic acquisitions are positives.
Clorox faces mounting near-term headwinds from rising costs, global economic pressures and intensifying competition, all of which threaten to weigh on its profitability in fiscal 2026.
Campbell's adjusted EPS is forecasted to decline 12-18% to a range of $2.40-$2.55. This outlook reflects the combined impact of tariffs, inflation, higher marketing investment and muted volume growth.
The overall cigarette industry has been bearing the brunt of the inflationary environment, which has affected Adult Tobacco Consumers’ spending patterns. Cigarette volumes declined in Q2.
Sherwin-Williams faces headwinds in the general industrial, coil and industrial wood markets. The slowdown in housing markets may also affect results. High interest rates are also a concern.
Innovative Medicine unit is showing a growth trend, driven by existing products like Darzalex, Tremfya and Erleada and continued uptake of new launches, including Spravato, Carvykti and Tecvayli.
Decent loan demand and expansion into new markets by opening financial centers are expected to support Bank of America. Also, digital enhancement will likely keep aiding cross-selling opportunities.
Central Garden & Pet advances digital, supply chain and product innovation while driving margin gains and M&A, backed by strong financials and a focused Cost and Simplicity program.
Intel’s leading position in PC market, strength in servers, growing clout in software, IoT & ADAS domains and headway in process technology are positive indicators of future growth prospects.
Target’s accelerating digital ecosystem, marketplace expansion, shrink improvement, and high-margin non-merchandise streams, supported by advanced tech and AI, enhance profitability and omnichannel scale.